Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap Up – What’s Next?

Bio-Rad Laboratories, Inc. (NYSE:BIO.B)’s share price gapped up before the market opened on Friday . The stock had previously closed at $247.05, but opened at $283.85. Bio-Rad Laboratories shares last traded at $284.88, with a volume of 300 shares.

Bio-Rad Laboratories Stock Up 15.3%

The firm has a 50-day simple moving average of $260.69 and a two-hundred day simple moving average of $250.53. The company has a debt-to-equity ratio of 0.17, a current ratio of 5.12 and a quick ratio of 3.67. The company has a market cap of $7.75 billion, a PE ratio of 24.29 and a beta of 0.81.

Bio-Rad Laboratories (NYSE:BIO.B) last posted its quarterly earnings data on Thursday, July 31st. The company reported $2.61 earnings per share (EPS) for the quarter. Bio-Rad Laboratories had a return on equity of 4.01% and a net margin of 12.50%.The business had revenue of $651.60 million for the quarter.

Bio-Rad Laboratories Company Profile

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.